Document is current
Any future updates will be listed below
-
Authors
Staab, Keegan R.
McIntosh, Marrissa J.
Puliyakote, Abhilash S. Kizhakke
Hahn, Andrew D.
AlArab, Natally
Percy, Jonathan L.
Lanning, Tara
Theeler, Johanna
Linkenmeyer, Carinda
Wharff, Conner J.
Bruening, Eric
Sieren, Jessica C.
Hoffman, Eric A.
Comellas, Alejandro P.
Hoth, Karin F.
Fain, Sean B.
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH NCATS S10OD026960, NIH CTSA program grant UM1TR004403, NIH NHLBI R01HL169765, NIH NHLBI R01HL126771)
American Lung Association (COVID-19 and Emerging Respiratory Viruses Research Award)
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 29 October 2025
First Online: 24 November 2025
Declarations
:
: SBF reports relationships with Siemens Healthcare, GE Healthcare, Polarean, Inc., and Regeneron Pharmaceuticals Inc. that include consulting, funded grants, and travel reimbursement. ADH reports relationships with Polarean, Inc. that includes consulting fees. EAH is a founder and shareholder of VIDA Diagnostics, a company commercializing lung image analysis software developed, in part, at the University of Iowa, & an unremunerated member of the Siemens Healthineers’ photon counting CT advisory board. APC reports relationships with VIDA Diagnostics that includes unremunerated consulting. KRS, MJM, ASK, NA, JLP, TL, JT, CL, CJW, EB, JCS and KH have no disclosures.
